Assistant Professor of Medicine @BCMHouston. Associate Program Director ID Fellowship. Co-Director- Transplant ID @StLukesHealthTX
Tweets/views=My own.
mcfDNA diagnostic stewardship strategies, as currently implemented, were not associated with higher PCI, possibly due to variable and suboptimal restriction policies across institutions, underscoring the need to optimize mcfDNA ordering practices.
Excellent session at @IchsGlobal with @SarwatKMD and Rodrigo Hasbun on the growing role of #mNGS testing in #ICH. Dr. Khalil reviewed plasma mcfDNA for pulmonary infections, and I spoke on integrating these technologies into clinical practice with focus on #stewardship.
Complex cases often teach the most!! Great Insights on managing aortic endograft infections! Proud of our BCM ID fellow, Dr. Haitham Alaithan, for an inspiring presentation. @IDWeekmtg@BCMIDFellowship@RizwanSohailMD
Managing aortic endograft infections is no small feat - they’re complex, rare, and often humbling. Our BCM ID fellow, Dr. Haitham Alaithan, delivered an excellent presentation @IDWeekmtg on our #BSLMC experience with these challenging cases. @SarwatKMD@BCMIDFellowship
Our brilliant PGY-3 Dr. Emily Xiao gave one of the best oral presentations I’ve heard—on antibiotic duration for CIED systemic infections @ IDWeek 2025 in Atlanta. Insightful, evidence-based, and flawlessly delivered. #ProudMentors@SarwatKMD@bcmhouston
Excited to co-host this dinner with my partner-in-crime, @SarwatKMD — gathering site investigators from Duke, @MayoClinic , Harvard, UCLA, Yale, Northwestern, UCSF, U of MI, and more. Together, we are defining the future of ID diagnostics in SOT and CV infections. @bcmhouston
🫀Echo Smarter, Not Harder!
Not all S. aureus bacteremia needs echo. Timing of blood culture positivity + PREDICT helps us strike the balance: catching endocarditis, sparing low-risk patients @RizwanSohailMD@bcmhouston@BCMIDFellowship
🔥just out in CID https://t.co/X8Mh6KZYl5
From Guidelines to Bedside: CIED Infection Management for the Primary Teams!
Internists, hospitalists & ED clinicians are often first to evaluate patients with CIED + bacteremia
We propose a simplified approach to guide care & improve outcomes, prior to ID and EP consultation
Bridging the Gap 🧠🩺❤️🩹
CIED infection guidelines: written by experts, understood by ... well, mostly other experts!
But guess who sees the patient first? ED docs, hospitalists, internists.
This paper is for them — less Latin, more guidance!
@bcmhouston@SarwatKMD@amjmed
The Next Step: Role of Metagenomic Next Generation Sequencing for Microbial Detection in Culture-negative Cardiovascular infections
✅ Just Accepted
✍️ @SarwatKMD@BCMHouston@RizwanSohailMD
🔗 https://t.co/VnsaG9As5P
When echoes echo doubt, and PET scans blink—mcfDNA might just whisper the truth!
Our take on ruling out CIED infections with serial plasma sequencing.@RizwanSohailMD@bcmhouston@BCMIDFellowship
We are teaming up with some of the sharpest minds to shake up ID diagnostics! 🚀 Time to turn 🧬 data into practice-changing evidence and make sure patients get the best care possible. Stay tuned—this could get contagious! 😉🦠 #Transplant#mNGS@bcmhouston@BCMIDFellowship
#mNGS is set to transform ID diagnostics, esp. in transplant patients & CV infections. Proud of our #Transplant ID faculty @SarwatKMD for leading a major multi-center effort (BCM, Harvard, Duke, Mayo, etc.) to understand its optimal use. Stay tuned! @BCMIDFellowship@bcmhouston
mcfDNA sequencing is particularly high yield and high impact in late onset infections in SOTR with detection of opportunitistic pathogens. #IDTwiiter#MedTwitter@TAInfDis
Plasma cfDNA sequencing shows promise in securing microbiologic diagnosis in infections in solid organ #transplant recipients, with positive clinical impact in 1 in 4 cases, identifying pathogens missed by traditional methods. @BCMIDFellowship@bcmhouston
https://t.co/tqqo6j6b1N